Article17 Jul 2026Dupilumab is Efficacious Regardless of Endoscopic Phenotype: Post Hoc Analysis of the LIBERTY EoE TREET StudyLearn more
Article17 Jul 2026Dupilumab Maintained Histologic and Endoscopic Improvements During the Open-Label Extension Period of the EoE KIDS StudyLearn more
Article16 Jul 2026LIBERTY ASTHMA QUEST Trial: Dupilumab Efficacy in Type 2 Asthma Patients on High-Dose ICSLearn more
Article15 Jul 2026LIBERTY ASTHMA QUEST Trial: Dupilumab Evidence Summary in Moderate-to-Severe Uncontrolled AsthmaLearn more
Article15 Jul 2026Dupilumab improves clinical outcomes in patients with severe asthma compared to other biologicsLearn more
Article15 Jul 2026LIBERTY ASTHMA QUEST Trial: Dupilumab Efficacy in Eosinophilic (≥500 cells/µL) and Allergic Asthma SubgroupsLearn more
Article15 Jul 2026LIBERTY ASTHMA TRAVERSE Trial: Long-Term Safety and Efficacy of Dupilumab in Moderate-to-Severe AsthmaLearn more